Revolutionary thrombectomy system offers safer, faster, and non-surgical vascular care solutions.
Surmodics has secured FDA clearance for its Pounce XL thrombectomy system, a game-changing device designed to treat blood clots in large peripheral arteries. The system introduces a purely mechanical approach to thrombectomy, bypassing the complications associated with traditional drug-based and aspiration techniques.
A Breakthrough for Peripheral Artery Disease
Peripheral artery disease (PAD) affects millions worldwide, often leading to severe complications like acute limb ischemia. Traditional treatments, such as thrombolytic drugs or surgery, come with risks like bleeding and lengthy recovery times. The Pounce XL system addresses these challenges, offering a safer, more efficient solution.
Key Features of the Pounce XL System
- Nitinol Baskets: Expand to capture and secure clots.
- Collection Funnel: Channels clots safely for removal.
- Delivery Catheter: Ensures precise placement with minimal tissue disruption.
The system’s compatibility with arterial diameters from 5.5 to 10 mm allows for versatile applications, including complex lower extremity blockages.
Benefits for Patients and Providers
- Faster recovery: Enables outpatient procedures without thrombolytic drugs.
- Reduced risks: Minimizes bleeding and hospitalization.
- Efficiency: Streamlines workflows for vascular surgeons, allowing precise and reliable clot removal.
Clinical and Commercial Outlook
Following FDA clearance, Surmodics launched limited market trials of the Pounce XL, receiving positive feedback from vascular surgeons for its safety, effectiveness, and ease of use. Plans are in place to expand availability in 2025, addressing the rising demand for minimally invasive vascular treatments.
Shaping the Future of Vascular Care
The Pounce XL system aligns with healthcare’s shift toward less invasive procedures, reducing hospital burdens and costs. With a projected thrombectomy market exceeding $2 billion by 2030, Surmodics is positioned to lead innovation in vascular health.
Follow MEDWIRE.AI for updates on groundbreaking FDA approvals reshaping patient care.
